Contact information
About Jere
Jere advises our clients on capital markets transactions and securities markets regulation. Jere also focuses on corporate law related questions.
Jere joined Borenius as an Associate in 2022. Prior to his graduation, Jere worked as a trainee at the firm.
Service areas
Selected references
- Advised Danske Bank and DNB Carnegie, as joint global coordinators, on Bioretec’s fully guaranteed rights issue of EUR 9.2 million – the first in Finland to utilise the new EU exemption framework
- Advises Nightingale Health on its transfer to the main market of Nasdaq Helsinki and on having its ADRs and B shares quoted on the OTCQX International market
- Advised Kesko Corporation on the issue of EUR 300 million green notes
- Advises Lifeline SPAC I on its pending de-SPAC combination with Canatu
- Advises Nixu Corporation on the voluntary recommended cash tender offer by DNV AS
- Advised Endomines on a change of domicile from Sweden to Finland, its listing on Nasdaq Helsinki, and an EUR 13 million IPO-style offering
Career
- Associate, Borenius, 2022–
Education
- Master of Laws, 2022, University of Turku, Finland
Languages
- English, Finnish
Related references and news
- Borenius advised investors on ICEYE’s two latest financing rounds
- Borenius advised Rebl Group Oyj in connection with its comprehensive refinancing
- Borenius advised Davie, part of Inocea Group, on its acquisition of Enersense Offshore Oy
- Borenius advised Danske Bank and DNB Carnegie, as joint global coordinators, on Bioretec’s fully guaranteed rights issue of EUR 9.2 million – the first in Finland to utilise the new EU exemption framework
- Borenius advised Merus Power on a directed share issue
